RACHELLE LEBRUN: Open Payments
NPI 1518589738 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$244 in 13 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $65 · 2025 $244
Food & beverage: $244
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Dexcom, Inc. | 1 | $28 |
| Biogen, Inc. | 1 | $27 |
| Corium, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
| Organon LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Amgen Inc. | 1 | $13 |
Products named: JARDIANCE, Dexcom G6 Transmitter, ZURZUVAE, Ozempic, Azstarys, MOUNJARO, Cologuard Collection Kit, NEXPLANON.
Industry payments across IN — which companies pay providers there.
